MEDICATION RECONCILIATION

AHRQ releases toolkit to help reduce adverse drug events

The Agency for Healthcare Research and Quality has released a new toolkit to help hospitals improve their medication reconciliation processes to reduce adverse drug events. » More

TECHNOLOGY

McKesson launches automated filling, dispensing solutions

McKesson High Volume Solutions recently launched a high-speed, automated prescription filling system for ambulatory pharmacies and an automated medication dispensing cabinet. » More

Resource Center: Oral Anticoagulation in Atrial Fibrillation

Atrial fibrillation afflicts more than 2.3 million persons in the United States and is expected to increase 2.5-fold by 2050. To find risk stratifying tools and articles on emerging oral anticoagulant therapies, click here.

CONTINUING EDUCATION

Medication therapy management and collaborative practice

Successful collaborative relationships with physicians and other healthcare providers greatly enhance patient care. Knowing how to build those relationships is job 1. Earn up to 2 CPE credits. » Click here to login and take the exams.

CLINICAL NEWS

Pre-op aspirin use leads to decreased risk of post-op complications in cardiac surgery patients, study finds

Aspirin taken within 5 days of cardiac surgery led to a significant decrease in the risk of postoperative complications, according to a study published in the October issue of Annals of Surgery. » More

Ranbaxy launches generic Caduet

Ranbaxy has launched an authorized generic version of Caduet in the U.S. market, as part of an agreement with Pfizer. » More

Teva introduces authorized generic birth-control pill

Teva Pharmaceuticals announced in a prepared statement that levonorgestrel/ethinyl estradiol and ethinyl estradiol tablets (Camrese Lo) are now available. » More

FDA ACTIONS

New formulation of extended-release opioid to be crush resistant

FDA approved a "crush-resistant" formulation of oxymorphone extended release (Opana ER, Endo Pharmaceuticals) with the intent to help patients with appropriate use of opioids. » More

Voices

•	Anticoagulation update
•	JP at Large
•	View from the Zoo
•	Viewpoints
•	Regulatory & Legal

Meetings & Events

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.